Discuss This Disease

4 free views remaining today

autosomal dominant nocturnal frontal lobe epilepsy 3

ICD-10 Codes

Related ICD-10:

Description

Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) is a rare seizure disorder characterized by clusters of motor brief seizures arising in sleep with hyperkinetic or tonic manifestations. This condition is often associated with the presence of an aura, followed by gasping, groaning, or other vocalization, and prominent motor accompaniment such as thrashing.

Key Features:

  • Clusters of nocturnal frontal lobe seizures
  • Motor brief seizures with hyperkinetic or tonic manifestations
  • Presence of an aura, often accompanied by vocalization and prominent motor activity

References:

  • [3] - Characterized by clusters of motor brief seizures arising in sleep with hyperkinetic or tonic manifestations.
  • [7] - Clinical features commonly include the presence of an aura, followed by gasping, groaning, or other vocalization, prominent motor accompaniment (thrashing, etc.).

Additional Characteristics

  • clusters of nocturnal frontal lobe seizures
  • motor brief seizures with hyperkinetic or tonic manifestations
  • presence of an aura, often accompanied by vocalization and prominent motor activity
  • gasping, groaning, or other vocalization
  • thrashing

Signs and Symptoms

Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) is a rare seizure disorder characterized by intermittent dystonia and/or choreoathetoid movements that occur during sleep. The symptoms can vary from simple arousal from sleep to dramatic muscle spasms and movements.

Some common signs and symptoms of ADNFLE include:

  • Sleep-related seizures: Seizures that occur during sleep, which can last from a few seconds to a few minutes.
  • Dystonia and choreoathetoid movements: Abnormal muscle contractions and movements that can cause sudden leg movements and screaming.
  • Abnormal behavior: Symptoms such as abnormal behavior, sleep disturbances, and difficulty responding to others or speaking.
  • Hypermotor epilepsy: Clusters of motor brief seizures arising in sleep with hyperkinetic or tonic manifestations.

It's worth noting that ADNFLE is a rare condition, and the symptoms can vary from person to person. If you suspect someone has this condition, it's essential to consult a medical professional for proper diagnosis and treatment.

References: * [10] A rare seizure disorder characterized by intermittent dystonia and/or choreoathetoid movements that occur during sleep. * [11] These seizures can last from a few seconds to a few minutes, and can vary from causing simple arousal from sleep, to dramatic muscle spasms and movements. * [12] Frontal lobe seizures are a type of epilepsy. Symptoms can include abnormal behavior and sleep disturbances. They often occur at night. * [13] Sleep-related hypermotor epilepsy may include several startling behaviors during sleep, including sudden leg movements and screaming. * [14] Sep 19, 2023 — Head and eye movement to one side. · Not responding to others or having trouble speaking. · Explosive screams, including profanities or laughter. * [15] It is characterized by clusters of motor brief seizures arising in sleep with hyperkinetic or tonic manifestations.

Additional Symptoms

  • Head and eye movement to one side
  • Not responding to others or having trouble speaking
  • Explosive screams, including profanities or laughter
  • Sleep-related seizures
  • Dystonia and choreoathetoid movements
  • Hypermotor epilepsy
  • abnormal behavior

Diagnostic Tests

Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) can be challenging to diagnose, but various diagnostic tests can help confirm the condition. Here are some of the key diagnostic tests for ADNFLE:

  • Electroencephalogram (EEG): An EEG is a non-invasive test that measures electrical activity in the brain. It can help detect abnormal electrical patterns associated with seizures [5]. In people with ADNFLE, EEG may show interictal abnormalities, which are changes in brain activity between seizures [9].
  • Video-EEG monitoring: This test combines EEG with video recording to monitor brain activity and behavior during a seizure. Video-EEG can be diagnostic when it shows electroclinical seizures of frontal lobe origin [7]. It is considered the best available diagnostic test for ADNFLE [10].
  • Magnetic Resonance Imaging (MRI): An MRI scan can help rule out other conditions that may cause similar symptoms, such as structural abnormalities in the brain. However, it is not typically used to diagnose ADNFLE directly.
  • Genetic testing: Genetic testing can identify mutations in genes associated with ADNFLE, such as CHRNA4, CHRNB2, and CHRNA2 [8]. This can be particularly useful for families with a history of the condition.

It's worth noting that diagnosis of ADNFLE often requires a combination of clinical evaluation, EEG, video-EEG monitoring, and genetic testing. A comprehensive diagnostic approach is essential to confirm the condition accurately.

References: [5] - The age of onset varies between 3 and 47 years (usually 20 years, with a peak during childhood).Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is defined by different motor events of increasing complexity and duration, arising during non-rapid eye movement sleep (NREM), including short-lasting (2-4 sec) stereotyped movements involving the limbs, axial musculature, and/or the head ... [7] - Video-EEG may be diagnostic when demonstrating electroclinical seizures of frontal lobe origin. The first gene identified was a missense mutation in a large ... [8] by SK Hwang · 2011 · Cited by 16 — Clinically available molecular genetic testing reveals mutations in three genes, CHRNA4, CHRNB2 and CHRNA2. [9] Interictal EEG abnormalities are rare, and, for anatomical and technical reasons, ictal recordings are often showing non-specific or inconclusive results. [10] Zucconi M, Asselta R, et al. Autosomal dominant nocturnal frontal lobe epilepsy: a video-polysomnographic and genetic appraisal of 40 patients and delineation of the epileptic syndrome. ... Diagnostic and Treatment Methods Relating to Autosomal Dominant ...

Additional Diagnostic Tests

  • Magnetic Resonance Imaging (MRI)
  • Genetic testing
  • Electroencephalogram (EEG)
  • Video-EEG monitoring

Treatment

Treatment Options for Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

ADNFLE is a rare form of epilepsy characterized by seizures that occur during sleep. While the exact cause of ADNFLE is unknown, various treatment options are available to manage the condition.

  • Anti-seizure medications: These are usually the first line of treatment for frontal lobe epilepsy, including ADNFLE. Medications like oxcarbazepine (Trileptal) or carbamazepine (Tegretol or Carbatrol) can be effective in controlling seizures.
  • Carbamazepine: This medication is particularly effective in treating nocturnal motor/dystonic frontal lobe seizures, which are a common type of seizure associated with ADNFLE [6].
  • Topiramate: Studies have shown that topiramate (TPM) can be an effective treatment option for patients with NFLE, including those with ADNFLE [7]. Topiramate has been found to be well-tolerated and effective in reducing the frequency of seizures.
  • Other anti-seizure medications: Newer medications such as gabapentin, lamotrigine, levetiracetam, zonisamide, pregabalin, lacosamide, and eslicarbazepine have also been used to treat ADNFLE. However, their effectiveness may vary from person to person [8].

It's essential to note that each individual with ADNFLE may respond differently to these treatment options. A healthcare professional can help determine the best course of treatment based on individual needs and medical history.

References: [3] These seizures often can be well controlled with anti-seizure medications like oxcarbazepine (Trileptal) or carbamazepine (Tegretol or Carbatrol). [6] Sep 25, 2018 — Carbamazepine is particularly effective in the treatment of nocturnal motor/dystonic frontal lobe seizures. [7] by A Oldani · 2006 · Cited by 54 — Aim of this study is to evaluate the efficacy and tolerability of the antiepileptic drug topiramate (TPM) in a sample of patients with NFLE. [8] Sep 25, 2018 — Newer anti-seizure medications include gabapentin, lamotrigine, topiramate, levetiracetam, zonisamide, oxcarbazepine, pregabalin, lacosamide, ...

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) can be challenging to diagnose, and it often requires a combination of clinical evaluation, electroencephalography (EEG), and genetic testing. Here are some key points to consider for the differential diagnosis of ADNFLE:

  • Misdiagnosis as nightmares: ADNFLE is often misdiagnosed as nightmares or parasomnia due to its nocturnal nature and brief seizure clusters [4][8].
  • Other potential diagnoses: Frontal lobe seizures, which are a type of epilepsy, can also present with abnormal behavior and sleep disturbances, making them a differential diagnosis for ADNFLE [9].
  • Importance of EEG testing: An EEG is essential for diagnosing ADNFLE, as it can help identify the characteristic brief seizure clusters during light sleep [3].
  • Genetic testing: Molecular genetic testing approaches, such as using a multigene panel, can be used to confirm the diagnosis of ADNFLE when phenotypic and EEG findings suggest the condition [2].

It's worth noting that nocturnal video-polysomnography is considered most helpful for differential diagnosis without it, ADNFLE is often misdiagnosed as benign nocturnal sleep-related events [7].

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1658
owl#annotatedSource
t341493
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0060684
core#notation
DOID:0060684
oboInOwl#hasDbXref
MIM:605375
IAO_0000115
An autosomal dominant nocturnal frontal lobe epilepsy that has_material_basis_in heterozygous mutation in the CHRNB2 gene on chromosome 1q21.
rdf-schema#label
autosomal dominant nocturnal frontal lobe epilepsy 3
oboInOwl#hasExactSynonym
nocturnal frontal lobe epilepsy 3
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0060681
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
relatedICD
http://example.org/icd10/R46.2
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.